NCT00543894

Brief Summary

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2006

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 11, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 15, 2007

Completed
Last Updated

August 12, 2008

Status Verified

June 1, 2007

First QC Date

October 11, 2007

Last Update Submit

August 11, 2008

Conditions

Infection in ICU

Keywords

Antibiotic, ICU, hospital acquired infection.

Outcome Measures

Secondary Outcomes (2)

  • the frequency of appropriate antibiotic therapy (defined as the use of antibiotic(s) with "in vitro" efficacy against the identified pathogens responsible for the infection)

  • the frequency of "the strategy of de-escalation" according to the culture results

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay
  • Hospital-acquired infections accounting for eligibility are:
  • nosocomial pneumonia (including ventilator-associated pneumonia)
  • bacteremia
  • intra-abdominal infections
  • urosepsis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cross Infection

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Pr Vogelaers

    UZ Gents

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 11, 2007

First Posted

October 15, 2007

Study Start

February 1, 2006

Last Updated

August 12, 2008

Record last verified: 2007-06